TrianglePUBLICATIONS · 18942073
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Surg Oncol
- Publication date
- 2009 Jan 1
- First author
- Eisenberg BL
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Eisenberg BL
- type
- Author
- name
- Harris J
- type
- Author
- name
- Blanke CD
- type
- Author
- name
- Demetri GD
- type
- Author
- name
- Heinrich MC
- type
- Author
- name
- Watson JC
- type
- Author
- name
- Hoffman JP
- type
- Author
- name
- Okuno S
- type
- Author
- name
- Kane JM
- type
- Author
- name
- von Mehren M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Eisenberg BL
- type
- Author
- name
- Harris J
- type
- Author
- name
- Blanke CD
- type
- Author
- name
- Demetri GD
- type
- Author
- name
- Heinrich MC
- type
- Author
- name
- Watson JC
- type
- Author
- name
- Hoffman JP
- type
- Author
- name
- Okuno S
- type
- Author
- name
- Kane JM
- type
- Author
- name
- von Mehren M
- type
- Author
- bibliography ids
- nci-bib-7cad36213e5e41bad9b8ed30
- book metadata
- content sha256
- 3732602be1ed9e3db248e5484ddc0e8c25f2ec5a1038ac8ed8389e2c684ab592
- document type
- citation
- dois
- 10.1002/jso.21160
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:18942073
- immutable id
- pubmed:18942073@3732602be1ed9e3db248e5484ddc0e8c25f2ec5a1038ac8ed8389e2c684ab592
- journal
- abbreviation
- J Surg Oncol
- issn electronic
- 1096-9098
- issn print
- 0022-4790
- issue
- 1
- name
- Journal of surgical oncology
- nlm unique id
- 0222643
- pages
- 42-7
- volume
- 99
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 18942073
- provenance
- batch id
- 6281e3e555c9a831cffc
- provider
- NCBI PubMed ESummary
- record sha256
- c7be7f59a038f9b29123582b9932d42d2ab205a6ae6dd257084e28ff487ac6ca
- response sha256
- 0bb4ba3914464c472d4206a84abe8224c9e76dc003114204593648964c5bf66c
- retrieved at
- 2026-09-09T23:46:21.772457+00:00
- publication date
- display
- 2009 Jan 1
- precision
- day
- year
- 2009
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- Research Support, U.S. Gov't, Non-P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.
Preserved source evidence · Not medical advice